세계의 뉴로테크 디바이스 시장 : 제품 유형별, 컨디션별, 최종 사용자별, 지역별

The global neurotech devices market was valued US$ 13.44 Bn in 2023 and is expected to reach US$ 37.04 Bn by 2031 growing at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

Figure 1. Global Neurotech Devices Market Share (%), By Region, 2024

Neurotech devices aim to treat a variety of neurological disorders by interfacing directly with the nervous system. These innovative technologies utilize implantable or wearable sensors and stimulating devices to collect neural data and potentially repair damaged pathways in the brain or spinal cord. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain that have proved difficult to treat with conventional therapies may potentially benefit from targeted neuromodulation approaches. The global neurotech devices market is still at a nascent stage but growing rapidly as new products enter clinical trials. Advanced materials and miniaturization of electronics have enabled the creation of biocompatible neural interfaces. Rising public awareness about neurological illnesses and growing government support for neuroscience research are some of the key factors anticipated to drive continued expansion of this market in the coming years.

Market Dynamics:

The neurotech devices market is driven by the rising global prevalence of neurological disorders, technological advancements in neural interfaces, growing demand for minimally invasive therapies, and increasing government funding for neuroscience research. However, factors such as high costs associated with clinical trials and product development, reimbursement challenges for new technologies, and biosafety concerns pertaining to long term device implantation pose significant challenges to market growth. Various startups and large companies have also started exploring applications of neurotech beyond therapeutics, in areas like augmented cognition, which presents lucrative commercial opportunities. Collaborations between researchers, medical device firms, and computing companies are likely to further accelerate the development of next-generation neurotech solutions.

Key features of the study:

• This report provides an in-depth analysis of the global neurotech devices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global neurotech devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Boston Scientific Corporation, BrainCo, Inc, Cochlear Limited, Control Bionics, Inc, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Natus medical Incorporated, Integra LifeSciences, Blackrock Microsystems, NeuroSigma, Inc., NeuroVigil Inc., Neuralink Corp., Abbott Laboratories, and Advanced Bionics AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global neurotech devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurotech devices market.

Detailed Segmentation:

• Global Neurotech Devices Market, By Product Type
  • Neurostimulation
  • Deep brain stimulator
  • Gastric electric stimulator
  • Spinal cord stimulator
  • Sacral nerve stimulator
  • Vagus nerve stimulator
  • Transcutaneous electrical nerve stimulation (TENS)
  • Other neurostimulations
  • Neuroprostheses
  • Neurosensing
  • Neurorehabilitation devices
• Global Neurotech Devices Market, By Conditions
  • Pain management
  • Cognitive disorders
  • Epilepsy
  • Urinary and fecal incontinence
  • Hearing conditions
  • Parkinson's disease
  • Depression
  • Sleep disorders
  • Essential tremor
  • Other conditions
• Global Neurotech Devices Market, By End User
  • Hospitals
  • Ambulatory surgical centers
  • Homecare facilities
  • Other end users
• Global Neurotech Devices Market, By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Top Companies in the Global Neurotech Devices Market:
  • Boston Scientific Corporation
  • BrainCo, Inc
  • Cochlear Limited
  • Control Bionics, Inc
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • Natus medical Incorporated
  • Integra LifeSciences
  • Blackrock Microsystems
  • NeuroSigma, Inc.
  • NeuroVigil Inc.
  • Neuralink Corp.
  • Abbott Laboratories
  • Advanced Bionics AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Conditions
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising incidence of neurological disorders
  • Integration of AI & IoT in neurotech devices
  • High cost of neurotech devices
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Product Launches
• Mergers, Acquisitions, and Collaborations

4. Global Neurotech Devices Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Neurotech Devices Market, By Product Type, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Neurostimulation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Neurostimulation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Deep brain stimulator
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Gastric electric stimulator
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Spinal cord stimulator
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Sacral nerve stimulator
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Vagus nerve stimulator
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Transcutaneous electrical nerve stimulation (TENS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Other neurostimulations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Neuroprostheses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Neurosensing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Neurorehabilitation devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Neurotech Devices Market, By Conditions, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pain management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Cognitive disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Epilepsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Urinary and fecal incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Hearing conditions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Parkinson's disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Depression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Sleep disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Essential tremor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Other conditions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Neurotech Devices Market, By End User, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Ambulatory surgical centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Homecare facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Other end users
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Neurotech Devices Market, By Region, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020 - 2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$
  • Market Size and Forecast, and Y-o-Y Growth, By Conditions, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profile
  • Boston Scientific Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BrainCo, Inc
  • Cochlear Limited
  • Control Bionics, Inc
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • Natus medical Incorporated
  • Integra LifeSciences
  • Blackrock Microsystems
  • NeuroSigma, Inc.
  • NeuroVigil Inc.
  • Neuralink Corp.
  • Abbott Laboratories
  • Advanced Bionics AG

Analyst Views

10. Section

• References
• Research Methodology
• About us